½ÃÀ庸°í¼­
»óǰÄÚµå
1665332

ÃøºÎÀÎ´ë ¾ÈÁ¤È­ ½Ã½ºÅÛ ½ÃÀå : ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

Collateral Ligament Stabilizer System Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÃøºÎÀÎ´ë ¾ÈÁ¤È­ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡ 24¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025³âºÎÅÍ 2034³â±îÁö CAGRÀº 6.3%·Î ¿¹ÃøµÇ¾î Å« ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ÀÌ È®´ë¿¡´Â ÀÇ·á±â¼úÀÇ ²÷ÀÓ¾ø´Â Áøº¸, ½ºÆ÷Ã÷ ¹× ½Åü Ȱµ¿ Âü¿© Áõ°¡, ¼±ÅÃÀû ¼ö¼ú Áõ°¡ µîÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ´Ù¾çÇÑ È¯ÀÚÃþ¿¡¼­ È¿°úÀûÀÎ ÀÎ´ë ¾ÈÁ¤È­ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ µÞ¹ÞħµË´Ï´Ù.

Collateral Ligament Stabilizer System Market-IMG1

Á¦Ç° À¯Çüº°·Î´Â ¹«¸­À屸 ¹× ¼­Æ÷ÅÍ, Á·ºÎ¿Í ¹ß¸ñÀ屸 ¹× ¼­Æ÷ÅÍ, ¼Õ¸ñÀ屸 ¹× ¼­Æ÷ÅÍ, ±âŸ °ü·Ã Á¦Ç°ÀÌ ÀÖ½À´Ï´Ù. ÀÌ Áß ¹«¸­À屸 ¹× ¼­Æ÷ÅͰ¡ 2024³â ½ÃÀåÀ» ¼®±ÇÇØ 11¾ï ´Þ·¯ÀÇ ¼öÀÍÀ» ¿Ã·È½À´Ï´Ù. Ãæ°ÝÀÌ Å« ½ºÆ÷Ã÷³ª ½Åü Ȱµ¿¿¡ ´ëÇÑ Âü°¡°¡ ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¹«¸­ÀÇ ºÎ»óÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¹«¸­ÀÇ ½ºÅºô¶óÀÌÀú´Â ºÎ»ó Èijª ¼ö¼ú ÈÄÀÇ È¸º¹¿¡ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â±¸´Â ¹«¸­ °üÀýÀ» ¾ÈÁ¤½Ã۰í, Ä¡À¯ Áß¿¡ ÀûÀýÇÑ Á¤·ÄÀ» º¸ÀåÇϰí, È¿°úÀûÀÎ ÀçȰÀ» À§ÇØ ÅëÁ¦µÈ ¿îµ¿À» °¡´ÉÇÏ°Ô ÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ, ƯÈ÷ ¼ö¼ú ÈÄ ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÌ ºÎ¹®ÀÇ À¶¼ºÀ» °è¼Ó °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 24¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 44¾ï ´Þ·¯
CAGR 6.3%

ÃøºÎÀÎ´ë ¾ÈÁ¤È­ ½Ã½ºÅÛ ½ÃÀåÀº µî±Þ I, µî±Þ II, µî±Þ IIIÀÇ ¼Õ»ó ºÐ·ù¿¡ ÀÇÇØ¼­µµ ±¸ºÐµË´Ï´Ù. 2024³â¿¡´Â µî±Þ IIIÀÌ ½ÃÀåÀÇ 40%¸¦ Â÷ÁöÇÏ¿© °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. µî±Þ IIIÀÇ ¼Õ»óÀº ÀδëÀÇ ¿ÏÀüÇÑ ´Ü¿­À» ¼ö¹ÝÇϹǷΠ°üÀýÀÌ ÇöÀúÇÏ°Ô ºÒ¾ÈÁ¤ÇØÁö°í ¿Ü°úÀû °³ÀÔÀ» Æ÷ÇÔÇÑ ÁýÁß Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ½ºÅºô¶óÀÌÀú ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ Áß»óÀ» °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀ̸ç Ä¡À¯ °úÁ¤°ú ¼ö¼ú ÈÄ È¸º¹¿¡ ÇʼöÀûÀÎ °üÀýÀÇ ¾ÈÁ¤¼ºÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÑ ºÎ»óÀ» Ä¡·áÇϱâ À§ÇØ °í±Þ ½ºÅºô¶óÀÌÀú ½Ã½ºÅÛÀÌ ÇÊ¿äÇÏ´Ù´Â °ÍÀº ÀÌ ºÎ¹® ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¹Ì±¹ÀÇ ÃøºÎÀÎ´ë ¾ÈÁ¤È­ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â 9¾ï 3,830¸¸ ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇßÀ¸¸ç, 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á Çõ½ÅÀÇ ¼¼°è ¸®´õÀÎ ¹Ì±¹Àº ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ÃÖ÷´Ü ½ºÅºô¶óÀÌÀú ½Ã½ºÅÛÀ» Ȱ¿ëÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Çâ»óµÈ Àç·á ¼³°è, °³¼±µÈ Á¶Á¤ ±â´É, °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â °³º° ¼Ö·ç¼ÇÀ» Ư¡À¸·Î Çϸç ÃÖÀûÀÇ °ü¸®¿Í ½Å¼ÓÇÑ È¸º¹À» º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ÀåºñÀÇ º¸±ÞÀº ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀåÀ» °¡¼ÓÇÏ°í ¹Ì±¹À» ÀÌ »ê¾÷¿¡¼­ Áß¿äÇÑ ÁøÃâ±â¾÷À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ºÆ÷Ã÷ ºÎ»ó Áõ°¡
      • ¼ö¼ú °Ç¼ö Áõ°¡
      • Á¦Ç° ¼³°èÀÇ ±â¼úÀû Áøº¸
      • ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • »ê¾÷ÀÇ ÀáÀçÀû ¸®½ºÅ© ¹× °úÁ¦
      • °í±Þ ½ºÅºô¶óÀÌÀú¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼ú
  • »óȯ ½Ã³ª¸®¿À
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °¸ ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå °æÀï ±¸µµ

  • ¼­¹®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Á¦Ç°º°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¹«¸­À屸 ¹× ¼­Æ÷ÅÍ
  • Á·ºÎ¿Í ¹ß¸ñÀ屸 ¹× ¼­Æ÷ÅÍ
  • ¼Õ¸ñÀ屸 ¹× ¼­Æ÷ÅÍ
  • ±âŸ

Á¦6Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Àδë À¯Çüº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¾ÈÂÊ ºÎÀδë(MCL)
  • ¿ÜÃø ºÎÀδë(LCL)
  • ±âŸ

Á¦7Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : »óÇØ À¯Çüº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • µî±Þ I
  • µî±Þ II
  • µî±Þ III

Á¦8Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Ä¡·áº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºñ¿Ü°úÀû Ä¡·á
  • ¿Ü°úÀû Ä¡·á

Á¦9Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • Á¤Çü¿Ü°ú Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦10Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • 3M
  • BAUERFEIND
  • Bio DYNAMIC TECHNOLOGIES
  • BREG
  • Corin
  • DARCO
  • DeRoyal
  • enovis
  • essity Health &Medical
  • HELY &WEBER
  • medi
  • MEDLINE
  • OSSUR
  • ottobock
  • THUASNE
AJY 25.03.27

The Global Collateral Ligament Stabilizer System Market, valued at USD 2.4 billion in 2024, is poised for significant growth, with a projected CAGR of 6.3% from 2025 to 2034. This expansion is fueled by continuous advancements in medical technology, increased participation in sports and physical activities, and a rising number of elective surgeries. These factors collectively underscore the growing demand for effective ligament stabilizer systems across diverse patient demographics.

Collateral Ligament Stabilizer System Market - IMG1

By product type, the market includes knee braces and supports, foot and ankle braces and supports, wrist braces and supports, and other related products. Among these, knee braces and supports dominated the market in 2024, generating USD 1.1 billion in revenue. The increasing global participation in high-impact sports and physical activities has led to a surge in knee injuries, making knee stabilizers a critical component in post-injury and post-surgical recovery. These devices play a vital role in stabilizing the knee joint, ensuring proper alignment during healing, and allowing controlled movement for effective rehabilitation. The demand for these devices, especially for post-surgical applications, continues to drive the prominence of this segment.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.4 Billion
Forecast Value$4.4 Billion
CAGR6.3%

The collateral ligament stabilizer system market is also segmented by injury classification, encompassing grade I, grade II, and grade III injuries. In 2024, the grade III segment accounted for the largest share, capturing 40% of the market. Grade III injuries involve complete ligament tears, resulting in significant joint instability and requiring intensive treatment, including surgical intervention. Stabilizer systems are indispensable for managing these severe injuries, providing essential joint stability during the healing process or post-surgical recovery. The necessity of advanced stabilizer systems for treating such complex injuries is a key factor propelling demand in this segment.

The U.S. collateral ligament stabilizer system market contributed USD 938.3 million in revenue in 2024 and is projected to grow at a CAGR of 5.9% through 2034. As a global leader in healthcare innovation, the U.S. benefits from advanced medical infrastructure and access to state-of-the-art stabilizer systems. These systems feature enhanced material designs, improved adjustability, and personalized solutions tailored to individual patient needs, ensuring optimal care and faster recovery. The widespread adoption of these innovative devices is driving robust market growth, positioning the U.S. as a key player in this industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of sports injuries
      • 3.2.1.2 Rise in number of surgical procedures
      • 3.2.1.3 Technological advancements in product design
      • 3.2.1.4 Growing investments in healthcare infrastructure
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with advanced stabilizers
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Knee braces and supports
  • 5.3 Foot and ankle braces and supports
  • 5.4 Wrist braces and supports
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Ligament Type, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Medial Collateral Ligament (MCL)
  • 6.3 Lateral Collateral Ligament (LCL)
  • 6.4 Other ligament types

Chapter 7 Market Estimates and Forecast, By Injury Type, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Grade I
  • 7.3 Grade II
  • 7.4 Grade III

Chapter 8 Market Estimates and Forecast, By Treatment, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Non-surgical treatment
  • 8.3 Surgical treatment

Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Orthopedic clinics
  • 9.4 Ambulatory surgical centers
  • 9.5 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 3M
  • 11.2 BAUERFEIND
  • 11.3 Bio DYNAMIC TECHNOLOGIES
  • 11.4 BREG
  • 11.5 Corin
  • 11.6 DARCO
  • 11.7 DeRoyal
  • 11.8 enovis
  • 11.9 essity Health & Medical
  • 11.10 HELY & WEBER
  • 11.11 medi
  • 11.12 MEDLINE
  • 11.13 OSSUR
  • 11.14 ottobock
  • 11.15 THUASNE
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦